ALNA
Vanguard Group’s Allena Pharmaceuticals, Inc. Common Stock ALNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,682,145
| Closed | -$512K | – | 4625 |
|
|
2022
Q2 | $512K | Buy |
2,682,145
+100,952
| +4% | +$19.3K | ﹤0.01% | 4288 |
|
|
2022
Q1 | $597K | Sell |
2,581,193
-709,562
| -22% | -$164K | ﹤0.01% | 4353 |
|
|
2021
Q4 | $1.95M | Buy |
3,290,755
+1,283,724
| +64% | +$761K | ﹤0.01% | 4046 |
|
|
2021
Q3 | $1.81M | Buy |
2,007,031
+45,887
| +2% | +$41.4K | ﹤0.01% | 4091 |
|
|
2021
Q2 | $2.55M | Buy |
1,961,144
+809,035
| +70% | +$1.05M | ﹤0.01% | 3897 |
|
|
2021
Q1 | $1.6M | Buy |
1,152,109
+550,562
| +92% | +$765K | ﹤0.01% | 3912 |
|
|
2020
Q4 | $770K | Buy |
601,547
+273,821
| +84% | +$351K | ﹤0.01% | 3891 |
|
|
2020
Q3 | $485K | Sell |
327,726
-90,897
| -22% | -$135K | ﹤0.01% | 3825 |
|
|
2020
Q2 | $661K | Sell |
418,623
-13,971
| -3% | -$22.1K | ﹤0.01% | 3704 |
|
|
2020
Q1 | $417K | Hold |
432,594
| – | – | ﹤0.01% | 3709 |
|
|
2019
Q4 | $1.18M | Hold |
432,594
| – | – | ﹤0.01% | 3595 |
|
|
2019
Q3 | $1.71M | Sell |
432,594
-35,596
| -8% | -$140K | ﹤0.01% | 3499 |
|
|
2019
Q2 | $1.91M | Sell |
468,190
-53,441
| -10% | -$217K | ﹤0.01% | 3492 |
|
|
2019
Q1 | $3.66M | Buy |
521,631
+96,401
| +23% | +$677K | ﹤0.01% | 3253 |
|
|
2018
Q4 | $2.32M | Buy |
425,230
+75,411
| +22% | +$411K | ﹤0.01% | 3329 |
|
|
2018
Q3 | $3.76M | Buy |
349,819
+7,400
| +2% | +$79.5K | ﹤0.01% | 3328 |
|
|
2018
Q2 | $4.46M | Buy |
342,419
+120,047
| +54% | +$1.56M | ﹤0.01% | 3248 |
|
|
2018
Q1 | $2.45M | Buy |
222,372
+36,179
| +19% | +$399K | ﹤0.01% | 3389 |
|
|
2017
Q4 | $1.87M | Buy |
+186,193
| New | +$1.87M | ﹤0.01% | 3447 |
|